1. Home
  2. CTRA vs VTRS Comparison

CTRA vs VTRS Comparison

Compare CTRA & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coterra Energy Inc.

CTRA

Coterra Energy Inc.

HOLD

Current Price

$34.58

Market Cap

19.6B

Sector

Energy

ML Signal

HOLD

Logo Viatris Inc.

VTRS

Viatris Inc.

HOLD

Current Price

$13.45

Market Cap

17.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTRA
VTRS
Founded
1989
1961
Country
United States
United States
Employees
N/A
30000
Industry
Oil & Gas Production
Medicinal Chemicals and Botanical Products
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.6B
17.2B
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
CTRA
VTRS
Price
$34.58
$13.45
Analyst Decision
Buy
Buy
Analyst Count
15
4
Target Price
$35.27
$13.50
AVG Volume (30 Days)
10.2M
8.2M
Earning Date
05-04-2026
05-07-2026
Dividend Yield
2.59%
3.52%
EPS Growth
49.33
N/A
EPS
2.24
N/A
Revenue
$7,645,000,000.00
$14,299,900,000.00
Revenue This Year
$12.95
$4.45
Revenue Next Year
$7.21
$1.79
P/E Ratio
$15.13
N/A
Revenue Growth
40.07
N/A
52 Week Low
$22.33
$6.85
52 Week High
$36.88
$16.47

Technical Indicators

Market Signals
Indicator
CTRA
VTRS
Relative Strength Index (RSI) 58.87 43.46
Support Level $23.03 $12.92
Resistance Level N/A $13.49
Average True Range (ATR) 1.10 0.36
MACD -0.06 0.01
Stochastic Oscillator 51.88 51.17

Price Performance

Historical Comparison
CTRA
VTRS

About CTRA Coterra Energy Inc.

Coterra Energy Inc is an independent oil and gas company engaged in the development, exploration, and production of oil, natural gas, and natural gas liquids (NGLs). Its operations are mainly concentrated in areas with hydrocarbon resources, which are conducive to multi-well, repeatable development programs, and include the Permian Basin located in Texas and New Mexico, the Marcellus Shale in northeast Pennsylvania, and the Anadarko Basin located in the mid-continent region in Oklahoma. The company operates in one segment, oil and natural gas development, exploration, and production, in the continental U.S.

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: